Researchers Hope to Prevent HIV from Turning to AIDS with Anti-Inflammatory Drug
December 26, 2013 5:16 PM
comment(s) - last by
They also discovered how immune cell death occurs during an HIV infection
Scientists from the Gladstone Institutes have found that limiting (and possibly eventually blocking) the activity of a certain protein can help immune cells survive during
an HIV infection
, the research team has pinpointed each molecular event that occurs when an HIV infection leads to AIDS, which has lead to the use of an existing anti-inflammatory drug to stop that process from happening.
During an HIV infection, a protein known as IFI16 sniffs out fragments of HIV DNA in infected immune cells. This then activates the human enzyme caspase-1 and leads to pyroptosis, which is a highly inflammatory form of cell death.
From there, a repetitive cycle of abortive infection, cell death, inflammation and the pulling in of additional CD4 T-cells to the infection eventually destroys the immune system, leading to AIDS.
The latest study was built on earlier research in 2010 from the lab of Warner C. Greene, MD, PhD, who directs virology and immunology research at Gladstone. At that time, it was found that immune cells commit suicide in an attempt to protect the body after being infected. The suicide is to stop the virus from spreading.
However, this causes destruction of the immune system and causes AIDS.
That's why the more recent Gladstone study aimed to
understand this process
better. With that knowledge, they could possibly stop it from happening. This is key, since the death of CD4 T-cells are the main cause of AIDS.
The research team used human spleen, tonsil and lymph node tissue from HIV-infected patients for the study. They genetically manipulated CD4 T cells in the tissue to identify the DNA sensor that finds fragments of HIV's DNA.
This helped them find that reducing the activity of the protein IFI16 inhibited pyroptosis. However, they can't block it entirely until they know all of its functions.
The team is now entering a Phase 2 trial that will test an existing anti-inflammatory medicine's ability to block inflammation and pyroptosis in those with HIV. They hope that the drug, which targets the body and not the virus, will prevent drug resistance and offer an alternative to antiretroviral medications.
This article is over a month old, voting and posting comments is disabled
12/27/2013 6:21:37 AM
So the cells kill themselves to try to prevent the spread of the virus. By stopping that one stops that cause of AIDS but what about the rapid proliferation of more viruses? Is it possible to allow the viruses to proliferate without also leading to AIDS?
"I want people to see my movies in the best formats possible. For [Paramount] to deny people who have Blu-ray sucks!" -- Movie Director Michael Bay
Bone Marrow Transplants Rid Two Men of HIV
July 3, 2013, 1:04 PM
Gamers Decipher Structure of AIDS Enzyme
September 19, 2011, 4:28 PM
Creationists are Mad About Google Doodle Depicting Evolution
November 24, 2015, 8:48 PM
DHS and TSA: Whoops, We Missed That 73 Airport Employees May be Terrorists
November 19, 2015, 2:16 PM
Star Wars Spinoff Film "Rogue One", Theme Park Attractions Announced
August 17, 2015, 12:20 PM
SpaceX Falcon 9's Seventh Supply Mission to ISS Ends w/ Fiery Stage 1 Explosion
June 28, 2015, 1:10 PM
Cool Science Video: Glowing Millipede Prowls the Nevada Desert
May 18, 2015, 12:00 PM
Newly Discovered Costa Rican Glass Frog is Kermit's Doppelgänger
April 22, 2015, 11:26 AM
Latest Blog Posts
Sceptre Airs 27", 120 Hz. 1080p Monitor/HDTV w/ 5 ms Response Time for $220
Dec 3, 2014, 10:32 PM
Costco Gives Employees Thanksgiving Off; Wal-Mart Leads "Black Thursday" Charge
Oct 29, 2014, 9:57 PM
"Bear Selfies" Fad Could Turn Deadly, Warn Nevada Wildlife Officials
Oct 28, 2014, 12:00 PM
The Surface Mini That Was Never Released Gets "Hands On" Treatment
Sep 26, 2014, 8:22 AM
ISIS Imposes Ban on Teaching Evolution in Iraq
Sep 17, 2014, 5:22 PM
More Blog Posts
Copyright 2016 DailyTech LLC. -
Terms, Conditions & Privacy Information